HLA-DR Alpha 2 Mediates Negative Signalling via Binding to Tirc7 Leading to Anti-Inflammatory and Apoptotic Effects in Lymphocytes In Vitro and In Vivo
2008

HLA-DR Alpha 2 and TIRC7: A New Pathway in Immune Regulation

publication 10 minutes Evidence: high

Author Information

Author(s): Bulwin Grit-Carsta, Wälter Stephanie, Schlawinsky Mirko, Heinemann Thomas, Schulze Anke, Höhne Wolfgang, Krause Gerd, Kalka-Moll Wiltrud, Fraser Patricia, Volk Hans-Dieter, Löhler Jürgen, Milford Edgar L., Utku Nalân

Primary Institution: CellAct Pharma GmbH, Berlin, Germany

Hypothesis

Does the interaction between HLA-DR alpha 2 and TIRC7 provide negative regulatory signals in lymphocytes?

Conclusion

The study reveals that HLA-DR alpha 2 binding to TIRC7 inhibits lymphocyte proliferation and induces apoptosis.

Supporting Evidence

  • HLA-DR alpha 2 binds to TIRC7, inhibiting lymphocyte activation.
  • Binding of HLA-DR alpha 2 to TIRC7 leads to decreased IFN-γ expression.
  • Soluble HLA-DR alpha 2 treatment induces apoptosis in CD4+ and CD8+ T cells.
  • TIRC7 and HLA-DR co-localize at the APC-T cell interaction site.
  • Targeting TIRC7 with HLA-DR alpha 2 reduces proinflammatory cytokine release.

Takeaway

This study shows that a protein called HLA-DR alpha 2 can tell immune cells to stop growing and even make them die, which helps control the immune response.

Methodology

The study used yeast two-hybrid screening, flow cytometry, and Western blot analysis to investigate the interaction between HLA-DR alpha 2 and TIRC7.

Limitations

The study primarily focuses on in vitro and mouse models, which may not fully represent human immune responses.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001576

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication